Wells Fargo & Company Lexaria Bioscience Corp. Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
A detailed history of Wells Fargo & Company transactions in Lexaria Bioscience Corp. stock. As of the latest transaction made, Wells Fargo & Company holds 2,500 shares of LEXX stock, worth $5,775. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,500
Previous 3,300
24.24%
Holding current value
$5,775
Previous $9,000
22.22%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding LEXX
# of Institutions
27Shares Held
1.06MCall Options Held
0Put Options Held
0-
Invenomic Capital Management LP Boston, MA476KShares$1.1 Million0.08% of portfolio
-
Geode Capital Management, LLC Boston, MA150KShares$347,4030.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA109KShares$251,8400.0% of portfolio
-
Gen Trust, LLC60KShares$138,6000.01% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL44.9KShares$103,7190.0% of portfolio
About Lexaria Bioscience Corp.
- Ticker LEXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,951,000
- Market Cap $13.7M
- Description
- Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...